Clinical Trials in Atlanta

Showing 10901-10920 of 19,805 trials

A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia

NCT04009577

The primary objective of the study is to evaluate the proportion of adult \[greater than or equal to (\>=) 18 years\] participants with insomnia disorder taking zolpidem tartrate immediate release (ZOL-IR) or zolpidem tartrate extended release (ZOL-ER), intermittently or frequently, who transition to lemborexant 5 milligram (mg) (LEM5) or 10 mg (LEM10) after 2 weeks of receiving LEM.

Insomnia

Eisai Inc.53 participantsStarted Jul 2019

Glendale, Arizona, United States • Sacramento, California, United States • San Diego, California, United States +14 more locations

COMPLETEDPhase 2< 1 mile

A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function

NCT02443155

This trial is conducted globally. The aim of this trial is to assess the clinical proof-of-principle of NNC0114-0006 and liraglutide on preservation of beta-cell function in adult subjects with newly diagnosed type 1 diabetes mellitus.

DiabetesDiabetes Mellitus, Type 1

Novo Nordisk A/S308 participantsStarted Nov 2015

La Jolla, California, United States • Northridge, California, United States • Aurora, Colorado, United States +105 more locations

A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia

A Clinical Proof-of-principle Trial in Adult Subjects With Newly Diagnosed Type 1 Diabetes Mellitus Investigating the Effect of NNC0114-0006 and Liraglutide on Preservation of Beta-cell Function

Find Trials by Condition in Atlanta

A Study of ALKS 5461 for Treatment Refractory Major Depressive Disorder (MDD)

Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer

Afrezza Safety and Pharmacokinetics Study in Pediatric Patients

A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before

A Research Study to Compare Insulin 287 Once a Week to Insulin Glargine (100 Units/mL) Once a Day in People With Type 2 Diabetes.

Clinical Endpoint Bioequivalence Study of Test and Reference Inhalation Products in Patients With COPD With Device Robustness

Essure (Model ESS310) Placement Rate Study

ZK-Epo Given With Carboplatin in Patients With Recurrent Ovarian Cancer

Dual Epicardial Endocardial Persistent Atrial Fibrillation (AF) Study

Rheos System for the Treatment of HFpEF Heart Failure

Study of CAD-1883 for Spinocerebellar Ataxia

Refametinib in Combination With Sorafenib in RAS Mutant Hepatocellular Carcinoma (HCC)

A Safety, Efficacy and Pharmacokinetics Study of CD11301 for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)

ARQ 197 for Participants With Relapsed or Refractory Germ Cell Tumors

Amifampridine Phosphate for the Treatment of Congenital Myasthenic Syndromes

Dose-Escalation Study Of Palbociclib + Nab-Paclitaxel In mPDAC

Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors

Cytoreductive Prostatectomy in Treating Patients With Newly Diagnosed, Metastatic Prostate Cancer